Posted on August 22, 2026 by pervial Survodutide (BI 456906): Dual GLP-1/Glucagon Receptor Agonist in Metabolic and MASH Research Survodutide is a dual GLP-1 and glucagon receptor agonist demonstrating potent efficacy across clinical trials for obesity, metabolic dysfunction, and stea Read more Survodutide (BI 456906): Dual GLP-1/Glucagon Receptor Agonist in Metabolic and MASH Research